Literature DB >> 29283612

Moving effective treatment for posttraumatic stress disorder to primary care: A randomized controlled trial with active duty military.

Jeffrey A Cigrang1, Sheila A Rauch2, Jim Mintz3, Antoinette R Brundige3, Jennifer A Mitchell4, Elizabeth Najera5, Brett T Litz6, Stacey Young-McCaughan3, John D Roache3, Elizabeth A Hembree7, Jeffrey L Goodie8, Scott M Sonnek9, Alan L Peterson3.   

Abstract

INTRODUCTION: Many military service members with PTSD do not receive evidence-based specialty behavioral health treatment because of perceived barriers and stigma. Behavioral health providers in primary care can deliver brief, effective treatments expanding access and reducing barriers and stigma. The purpose of this randomized clinical trial was to determine if a brief cognitive-behavior therapy delivered in primary care using the Primary Care Behavioral Health model would be effective at reducing PTSD and co-occurring symptoms.
METHOD: A total of 67 service members (50 men, 17 women) were randomized to receive a brief, trauma-focused intervention developed for the primary care setting called Prolonged Exposure for Primary Care (PE-PC) or a delayed treatment minimal contact control condition. Inclusion criteria were significant PTSD symptoms following military deployment, medication stability, and interest in receiving treatment for PTSD symptoms in primary care. Exclusion criteria were moderate or greater risk of suicide, severe brain injury, or alcohol/substance use at a level that required immediate treatment. Assessments were completed at baseline, posttreatment/postminimal contact control, and at 8-week and 6-month posttreatment follow-up points. Primary measures were the PTSD Symptom Scale-Interview and the PTSD Checklist-Stressor-Specific.
RESULTS: PE-PC resulted in larger reduction in PTSD severity and general distress than the minimal contact control. Delayed treatment evidenced medium to large effects comparable to the immediate intervention group. Treatment benefits persisted through the 6-month follow-up of the study. DISCUSSION: PE-PC delivered in integrated primary care is effective for the treatment of PTSD and co-occurring symptoms and may help reduce barriers and stigma found in specialty care settings. (PsycINFO Database Record (c) 2017 APA, all rights reserved).

Entities:  

Mesh:

Year:  2017        PMID: 29283612     DOI: 10.1037/fsh0000315

Source DB:  PubMed          Journal:  Fam Syst Health        ISSN: 1091-7527            Impact factor:   1.950


  17 in total

1.  Validation of an Expanded Measure of Integrated Care Provider Fidelity: PPAQ-2.

Authors:  Gregory P Beehler; Jennifer S Funderburk; Paul R King; Kyle Possemato; John A Maddoux; Wade R Goldstein; Michael Wade
Journal:  J Clin Psychol Med Settings       Date:  2020-03

2.  Depression Suppresses Treatment Response for Traumatic Loss-Related Posttraumatic Stress Disorder in Active Duty Military Personnel.

Authors:  Vanessa M Jacoby; Willie Hale; Kirsten Dillon; Katherine A Dondanville; Jennifer Schuster Wachen; Jeffrey S Yarvis; Brett T Litz; Jim Mintz; Stacey Young-McCaughan; Alan L Peterson; Patricia A Resick
Journal:  J Trauma Stress       Date:  2019-08-28

Review 3.  The Role of Integrated Primary Care in Increasing Access to Effective Psychotherapies in the Veterans Health Administration.

Authors:  Kyle Possemato; Robyn L Shepardson; Jennifer S Funderburk
Journal:  Focus (Am Psychiatr Publ)       Date:  2018-10-18

4.  Effectiveness of currently available psychotherapies for post-traumatic stress disorder and future directions.

Authors:  Sonya B Norman
Journal:  World Psychiatry       Date:  2022-06       Impact factor: 49.548

5.  The Impact of Brief Interventions on Functioning Among those Demonstrating Anxiety, Depressive, and Adjustment Disorder Symptoms in Primary Care: The Effectiveness of the Primary Care Behavioral Health (PCBH) Model.

Authors:  Kevin M Wilfong; Jeffrey L Goodie; Justin C Curry; Christopher L Hunter; Phillip C Kroke
Journal:  J Clin Psychol Med Settings       Date:  2021-10-09

6.  Improving function through primary care treatment of PTSD: The IMPACT study protocol.

Authors:  Sheila A M Rauch; H Myra Kim; Ron Acierno; Carly Ragin; Bethany Wangelin; Kimberly Blitch; Wendy Muzzy; Stephanie Hart; Kara Zivin; Jeffrey Cigrang
Journal:  Contemp Clin Trials       Date:  2022-08-12       Impact factor: 2.261

7.  Brief novel therapies for PTSD: Written Exposure Therapy.

Authors:  Johanna Thompson-Hollands; Brian P Marx; Denise M Sloan
Journal:  Curr Treat Options Psychiatry       Date:  2019-06-05

8.  Neural affective mechanisms associated with treatment responsiveness in veterans with PTSD and comorbid alcohol use disorder.

Authors:  Katia M Harlé; Alan N Simmons; Sonya B Norman; Andrea D Spadoni
Journal:  Psychiatry Res Neuroimaging       Date:  2020-08-20       Impact factor: 2.376

9.  Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder.

Authors:  Lisa S Meredith; Miriam S Komaromy; Matthew Cefalu; Cristina Murray-Krezan; Kimberly Page; Karen Chan Osilla; Alex R Dopp; Isabel Leamon; Lina Tarhuni; Grace Hindmarch; Vanessa Jacobsohn; Katherine E Watkins
Journal:  Contemp Clin Trials       Date:  2021-03-10       Impact factor: 2.226

10.  Presence of PTSD is Associated with Clinical and Functional Impact in Veterans with Depression Treated in Community-Based Clinics.

Authors:  Fenan S Rassu; Shubhada Sansgiry; Natalie E Hundt; Mark E Kunik; Jeffrey A Cully
Journal:  J Clin Psychol Med Settings       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.